Phathom Pharmaceuticals, Inc.
PHAT$556M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaFLORHAM PARK427 employees
Drugs in Pipeline
3
Phase 3 Programs
3
Upcoming Catalysts
2
Next Catalyst
Aug 6, 2026
6wMarket Overview
Stock performance and key metrics
PHAT News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
Amoxicillin
Helicobacter Pylori Infection
Lansoprazole
Erosive Esophagitis
Vonoprazan
Non-Erosive Gastro-Esophageal Reflux Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Amoxicillin | Phase 3 | Helicobacter Pylori Infection | - | - |
Lansoprazole | Phase 3 | Erosive Esophagitis | - | - |
Vonoprazan | Phase 3 | Non-Erosive Gastro-Esophageal Reflux Disease | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply